12:00 AM
 | 
Apr 18, 2016
 |  BC Week In Review  |  Clinical News  |  Clinical Results

Bone-forming cells: Additional Phase IIa data

Additional data from 7 patients ages 40-85 who did not respond to anti-osteoporotic therapy in an investigator-led, open-label, Belgian Phase IIa trial showed that a single infusion of IV Preob led to a >=40% reduction in pain, with a maximum reduction...

Read the full 181 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >